Anemia Clinical Trials

Find Anemia Clinical Trials Near You

Tranexamic Acid for Perioperative Haemostatic Optimisation During Transurethral Resection of the Prostate: A Randomized Quadruple-Blind Placebo-Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Transurethral resection of the prostate (TURP) is commonly performed in elderly patients and may be associated with perioperative bleeding leading to postoperative anemia and delayed recovery. Tranexamic acid (TXA), an antifibrinolytic agent, may reduce surgical bleeding by inhibiting fibrin degradation. This prospective randomized quadruple-blind placebo-controlled clinical trial evaluates whether perioperative administration of intravenous tranexamic acid reduces intraoperative blood loss and preserves postoperative hemoglobin concentration in patients undergoing TURP under standardized spinal anesthesia. Participants are randomly assigned to receive either intravenous tranexamic acid or placebo prior to surgery. The primary outcomes assess objective measures of perioperative blood loss and postoperative hemoglobin levels. Secondary outcomes include recovery parameters, perioperative safety, and exploratory hospital-level economic impact. The study aims to determine whether anesthesia-led haemostatic optimization using tranexamic acid improves perioperative physiological stability and recovery efficiency within an enhanced recovery framework.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 50
Healthy Volunteers: f
View:

• Male patients aged 50 years or older

• Diagnosed with benign prostatic hyperplasia (BPH)

• Scheduled for elective transurethral resection of the prostate (TURP) under spinal anesthesia

• American Society of Anesthesiologists (ASA) physical status I-III

• Provided written informed consent

Locations
Other Locations
Morocco
Mohammed V Military Teaching Hospital
RECRUITING
Rabat
Time Frame
Start Date: 2026-03-30
Estimated Completion Date: 2026-10-30
Participants
Target number of participants: 80
Treatments
Experimental: Tranexamic Acid Group
Participants receive intravenous tranexamic acid (10 mg/kg) administered approximately 30 minutes before transurethral resection of the prostate under standardized spinal anesthesia.
Placebo_comparator: Placebo Group
Participants receive an identical volume of normal saline placebo administered intravenously prior to surgery under standardized spinal anesthesia.
Sponsors
Leads: Hamza Najout

This content was sourced from clinicaltrials.gov